Answer the following questions in about 150 words each :
(b) What do you mean by virus of bacteria? Describe their application in medical sciences.
10 marks · answer in 150 words · directive: Describe
The core of a good answer
Viruses of bacteria are bacteriophages, obligate intracellular parasites of bacteria that multiply by lytic or lysogenic cycles; in medicine they are used for phage therapy against drug-resistant infections, phage typing and diagnosis, phage display of antibodies, and as cloning tools, and they also explain toxin production by some pathogens.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
Two marks go to a precise definition with structure and life cycle; eight marks to applications in medical science. 'Describe' needs concrete, named uses rather than a general list.
Answer outline
Introduction
Bacteriophages ('bacteria eaters') were discovered independently by Frederick Twort (1915) and Felix d'Herelle (1917); they are viruses whose host is a bacterial cell.
What a bacteriophage is
- A protein capsid enclosing DNA or RNA; tailed phages such as T4 have a head, a contractile or non-contractile tail, base plate and tail fibres for attachment.
- Lytic cycle: adsorption, injection of the genome, takeover of host machinery, assembly and lysis of the cell by endolysin.
- Lysogenic cycle: temperate phages such as lambda integrate as a prophage and replicate with the host until induced.
- Host specificity is high, often down to strain level.
Phage therapy
- Lytic phages kill specific pathogens while sparing normal flora; used for decades in Georgia (Eliava Institute, founded 1923), Russia and Poland.
- Renewed interest because of multidrug resistance: compassionate-use cures against Pseudomonas aeruginosa, Acinetobacter baumannii and Mycobacterium abscessus; in February 2019 the US FDA approved the first clinical trial of intravenously administered phage therapy in the United States.
- Phage cocktails reduce the risk of resistance; isolated phage enzymes such as lysins have been added to the antimicrobial arsenal.
Diagnosis and epidemiology
- Phage typing schemes were developed for Salmonella Typhi and Staphylococcus aureus and were used through the 1900s to trace outbreaks; genotypic methods such as whole genome sequencing have since replaced them.
Biotechnology for medicine
- Phage display (first described by George Smith in 1985; Nobel Prize in Chemistry 2018 shared with Gregory Winter) selects antibodies and peptides, mostly on M13 and fd filamentous phages; adalimumab is listed among its successes.
- The CRISPR system is one of the bacterial defences against phages.
Understanding disease
- Lysogenic conversion: phage genes make Corynebacterium diphtheriae and Vibrio cholerae toxigenic, explaining diphtheria and cholera toxins.
Conclusion
Phages are both tools and therapies; with antimicrobial resistance rising, they are a serious complement to antibiotics, though regulation, specificity and resistance remain hurdles.
Examples and data to cite
- 1915: Twort; 1917: d'Herelle named the bacteriophage and proposed therapy.
- 1952: Hershey and Chase used T2 phage to show DNA is the genetic material.
- 2016 and 2017: compassionate phage treatments of a chronic Pseudomonas aeruginosa infection and, by intravenous drip at UC San Diego, an Acinetobacter baumannii infection.
- 2018: Nobel Prize in Chemistry to Smith and Winter for phage display.
Facts to remember
- Lytic phages are preferred for therapy; temperate phages can transfer virulence genes.
- No defined therapeutic phage product has yet reached the EU or US markets; Western use is mostly through trials and compassionate use.
- Lysogenic conversion by phages turns harmless strains of Corynebacterium diphtheriae into virulent diphtheria-causing strains; Vibrio cholerae is a similar case.